Clinical Characteristics
. | Cases . | ||||||
---|---|---|---|---|---|---|---|
1 . | 2 . | 3 . | 4 . | 5 . | 6 . | 7 . | |
Age of onset (erythroderma) | 2 mo | 2 mo | 2 wk | 4 mo | 4 mo | 2 mo | 2 wk |
Facial anomalies | + | − | − | +++ | − | − | − |
Thymic abnormalities | +++ | na* | ++ | +++ | na | na | ++ |
Erythroderma/exfoliative dermatitis | ++ | ++ | + | +++ | + | + | + |
Hepatomegaly | ++ | ++ | ++ | ++ | +++ | ++ | + |
Lymphadenopathy | ++ | ++ | ++ | +++ | +++ | ++ | + |
Diarrhea | ++ | ++ | ++ | ++ | ++ | +++ | ++ |
Failure to thrive | + | ++ | + | +++ | ++ | +++ | + |
Pulmonary edema | ++ | − | − | ++ | − | − | − |
Lymphocytosis | + | nl | nl | +++ | nl | ++ | + |
Eosinophilia | + | + | ++ | ++ | nl | + | + |
IgG | nl | dec | dec | dec | dec | dec | nl |
IgE | na | inc | inc | na | inc | inc | inc |
. | Cases . | ||||||
---|---|---|---|---|---|---|---|
1 . | 2 . | 3 . | 4 . | 5 . | 6 . | 7 . | |
Age of onset (erythroderma) | 2 mo | 2 mo | 2 wk | 4 mo | 4 mo | 2 mo | 2 wk |
Facial anomalies | + | − | − | +++ | − | − | − |
Thymic abnormalities | +++ | na* | ++ | +++ | na | na | ++ |
Erythroderma/exfoliative dermatitis | ++ | ++ | + | +++ | + | + | + |
Hepatomegaly | ++ | ++ | ++ | ++ | +++ | ++ | + |
Lymphadenopathy | ++ | ++ | ++ | +++ | +++ | ++ | + |
Diarrhea | ++ | ++ | ++ | ++ | ++ | +++ | ++ |
Failure to thrive | + | ++ | + | +++ | ++ | +++ | + |
Pulmonary edema | ++ | − | − | ++ | − | − | − |
Lymphocytosis | + | nl | nl | +++ | nl | ++ | + |
Eosinophilia | + | + | ++ | ++ | nl | + | + |
IgG | nl | dec | dec | dec | dec | dec | nl |
IgE | na | inc | inc | na | inc | inc | inc |
Abbreviations: na, not assessed; nl, normal; dec, decreased; inc, increased.